FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Arthritis Res Ther / Inflammatory mediators and cartilage biomarkers in synovial ...
Arthritis research & therapy2009; 11(2); R35; doi: 10.1186/ar2640

Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study.

Abstract: Inflammation is an important feature of many joint diseases, and levels of cartilage biomarkers measured in synovial fluid may be influenced by local inflammatory status. Little is known about the magnitude and time course of inflammation-induced changes in cartilage tissue turnover as measured in vivo by synovial fluid markers. We aimed to study temporal changes in concentrations of inflammatory mediators, matrix metalloproteinase activity and cartilage biomarkers over 1 week in joints with experimentally induced inflammation. Methods: Localized inflammation was induced in the intercarpal joint of six horses by sterile injection of 0.5 ng lipopolysaccharide, and synovial fluid was collected at post-injection hours (PIH) 0, 8, 24 and 168. Concentrations of inflammatory mediators (prostaglandin E2, substance P, and bradykinin), general matrix metalloproteinase activity and markers of collagen II turnover (CPII and C2C) as well as aggrecan turnover (CS846 and glycosaminoglycans) were measured with appropriate assays. One-way analysis of variance on repeated measures was used to analyze differences in synovial fluid marker levels over time. Results: Lipopolysaccharide-injection led to a sharp rise in prostaglandin E2 at PIH 8, while substance P, bradykinin and matrix metalloproteinase activity showed more sustained increases at PIH 8 and 24. Glycosaminoglycan release paralleled changes in the CS846 epitope, with an increase by PIH 8, a peak at PIH 24, and return to baseline by PIH 168. For type II collagen, a parallel time course between catabolic (C2C) and anabolic (CPII) markers was also observed, but the time course differed from that seen for proteoglycan markers: collagen II markers peaked later, at PIH 24, and were still elevated over baseline at PIH 168. Conclusions: A primary intra-articular inflammatory insult, characterized by local release of peptide and lipid mediators and matrix metalloproteinase activation, can alter synovial fluid levels of proteoglycan biomarkers as early as 8 hours post-induction, and can lead to sustained rises in collagen II biomarkers during at least 1 week after onset.
Get Full Text
Publication Date: 2009-03-09 PubMed ID: 19272138PubMed Central: PMC2688180DOI: 10.1186/ar2640Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research aimed to understand the changes that occur in joint inflammation, particularly regarding biomarkers in synovial fluid. The researchers induced inflammation in the joints of six horses and monitored the fluctuations in inflammatory mediators, enzyme activity, and cartilage biomarkers over a period of one week. They discovered that inflammation can rapidly affect synovial fluid levels of specific biomarkers and leads to sustained increases in collagen II biomarkers for at least a week after onset.

Methodology

  • The research team induced localized inflammation in the intercarpal joint of six horses by sterile injection of 0.5 ng lipopolysaccharide.
  • Synovial fluid was extracted from each horse at four different post-injection hours (PIH) – 0, 8, 24 and 168.
  • Specific inflammatory mediators in the collected synovial fluid including prostaglandin E2, substance P, and bradykinin were measured with appropriate assays.
  • Alongside, they also gauged the general matrix metalloproteinase activity (enzymes that contribute to the breakdown of matrix tissues) and markers of collagen II turnover (CPII and C2C), and aggrecan turnover (CS846 and glycosaminoglycans).
  • One-way analysis of variance on repeated measures was used to compare differences in synovial fluid marker levels over time.

Results

  • Lipopolysaccharide injection resulted in a steep surge in prostaglandin E2 at PIH 8. Substance P, bradykinin, and matrix metalloproteinase activity, however, showed sustained elevations at PIH 8 and 24.
  • Release of glycosaminoglycan mirrored changes in the CS846 epitope, with an enhancement by PIH 8, a peak at PIH 24, and an eventual return to baseline by PIH 168.
  • As for type II collagen, both catabolic (C2C) and anabolic (CPII) markers had a similar time course but differed from the time course of proteoglycan markers. Collagen II markers displayed a peak later, at PIH 24, and remained beyond the baseline at PIH 168.

Conclusions

  • The research confirmed that primary intra-articular inflammation can rapidly alter synovial fluid levels of proteoglycan biomarkers as early as 8 hours after induction.
  • It also demonstrated that inflammation can lead to sustained rises in collagen II biomarkers for at least 1 week after onset. This inflammatory insult is accompanied by the local release of peptide and lipid mediators and matrix metalloproteinase activation.

This study offers valuable insights into the dynamics of joint inflammation and its potential implications on the progression and diagnosis of joint diseases.

Cite This Article

APA
de Grauw JC, van de Lest CH, van Weeren PR. (2009). Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther, 11(2), R35. https://doi.org/10.1186/ar2640

Publication

Arthritis research & therapy
ISSN: 1478-6362
NlmUniqueID: 101154438
Country: England
Language: English
Volume: 11
Issue: 2
Pages: R35

Researcher Affiliations

de Grauw, Janny C
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. j.c.degrauw@uu.nl
van de Lest, Chris H A
    van Weeren, Paul René

      MeSH Terms

      • Animals
      • Arthritis, Experimental / metabolism
      • Biomarkers / analysis
      • Cartilage, Articular / chemistry
      • Cartilage, Articular / metabolism
      • Enzyme-Linked Immunosorbent Assay
      • Female
      • Horses
      • Inflammation Mediators / analysis
      • Inflammation Mediators / metabolism
      • Synovial Fluid / chemistry
      • Synovial Fluid / metabolism

      References

      This article includes 44 references
      1. Loeuille D, Chary-Valckenaere I, Champigneulle J, Rat AC, Toussaint F, Pinzano-Watrin A, Goebel JC, Mainard D, Blum A, Pourel J, Netter P, Gillet P. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity.. Arthritis Rheum 2005 Nov;52(11):3492-501.
        doi: 10.1002/art.21373pubmed: 16255041google scholar: lookup
      2. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis.. Ann Rheum Dis 2007 Dec;66(12):1599-603.
        doi: 10.1136/ard.2006.067470pmc: PMC2095318pubmed: 17491096google scholar: lookup
      3. Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, Barrett-Jolley R, Mobasheri A. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis.. Vet J 2009 Jan;179(1):10-24.
        doi: 10.1016/j.tvjl.2007.08.013pubmed: 17911037google scholar: lookup
      4. Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, Bohlig AM, Cutler BL, Yan C, Jaffe M. Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis.. Arthritis Rheum 2001 Jul;44(7):1599-607.
        doi: 10.1002/1529-0131(200107)44:7<1599::AID-ART283>3.0.CO;2-Npubmed: 11465711google scholar: lookup
      5. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB. Classification of osteoarthritis biomarkers: a proposed approach.. Osteoarthritis Cartilage 2006 Aug;14(8):723-7.
        doi: 10.1016/j.joca.2006.04.001pubmed: 16733093google scholar: lookup
      6. Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.. Arthritis Rheum 2004 Feb;50(2):543-52.
        doi: 10.1002/art.20027pubmed: 14872497google scholar: lookup
      7. Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.. J Rheumatol 1996 Oct;23(10):1765-9.
        pubmed: 8895155
      8. Henrotin Y, Addison S, Kraus V, Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Curr Opin Rheumatol 2007 Sep;19(5):444-50.
        doi: 10.1097/BOR.0b013e32829fb3b5pubmed: 17762609google scholar: lookup
      9. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.. Arthritis Rheum 2003 Nov;48(11):3085-95.
        doi: 10.1002/art.11331pubmed: 14613270google scholar: lookup
      10. Ishiguro N, Ito T, Oguchi T, Kojima T, Iwata H, Ionescu M, Poole AR. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.. Arthritis Rheum 2001 Nov;44(11):2503-11.
        doi: 10.1002/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-Ppubmed: 11710706google scholar: lookup
      11. Myers SL, Brandt KD, Eilam O. Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Implications for measurement of synovial fluid "markers" of osteoarthritis.. Arthritis Rheum 1995 Aug;38(8):1085-91.
        doi: 10.1002/art.1780380810pubmed: 7639804google scholar: lookup
      12. Kraus VB, Huebner JL, Fink C, King JB, Brown S, Vail TP, Guilak F. Urea as a passive transport marker for arthritis biomarker studies.. Arthritis Rheum 2002 Feb;46(2):420-7.
        doi: 10.1002/art.10124pubmed: 11840444google scholar: lookup
      13. Poole AR. An introduction to the pathophysiology of osteoarthritis.. Front Biosci 1999 Oct 15;4:D662-70.
        doi: 10.2741/Poolepubmed: 10525481google scholar: lookup
      14. Garnero P, Delmas PD. Biomarkers in osteoarthritis.. Curr Opin Rheumatol 2003 Sep;15(5):641-6.
        doi: 10.1097/00002281-200309000-00020pubmed: 12960494google scholar: lookup
      15. Koch TG, Betts DH. Stem cell therapy for joint problems using the horse as a clinically relevant animal model.. Expert Opin Biol Ther 2007 Nov;7(11):1621-6.
        doi: 10.1517/14712598.7.11.1621pubmed: 17961087google scholar: lookup
      16. Laverty S, Sandy JD, Celeste C, Vachon P, Marier JF, Plaas AH. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.. Arthritis Rheum 2005 Jan;52(1):181-91.
        doi: 10.1002/art.20762pubmed: 15641100google scholar: lookup
      17. Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.. Gene Ther 2002 Jan;9(1):12-20.
        doi: 10.1038/sj.gt.3301608pubmed: 11850718google scholar: lookup
      18. McIlwraith CW. General pathobiology of the joint and response to injury. In: McIlwraith CW, Trotter GW, editor. Joint Disease in the Horse. Philadelphia: W.B. Saunders; 1996. pp. 40–70.
      19. Morton AJ, Campbell NB, Gayle JM, Redding WR, Blikslager AT. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.. Res Vet Sci 2005 Apr;78(2):189-92.
        doi: 10.1016/j.rvsc.2004.07.006pubmed: 15563928google scholar: lookup
      20. Khumsap S, Lanovaz JL, Rosenstein DS, Byron C, Clayton HM. Effect of induced unilateral synovitis of distal intertarsal and tarsometatarsal joints on sagittal plane kinematics and kinetics of trotting horses.. Am J Vet Res 2003 Dec;64(12):1491-5.
        doi: 10.2460/ajvr.2003.64.1491pubmed: 14672426google scholar: lookup
      21. Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S. Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride.. Osteoarthritis Cartilage 2009 Feb;17(2):228-34.
        doi: 10.1016/j.joca.2008.06.018pubmed: 18692410google scholar: lookup
      22. Palmer JL, Bertone AL. Experimentally-induced synovitis as a model for acute synovitis in the horse.. Equine Vet J 1994 Nov;26(6):492-5.
        pubmed: 7889925doi: 10.1111/j.2042-3306.1994.tb04056.xgoogle scholar: lookup
      23. Ross MW. The lameness score: quantification of lameness severity. In: Ross MW, Dyson SJ, editor. Diagnosis and Management of Lameness in the Horse. Philadelphia: W.B. Saunders; 2003. pp. 66–67.
      24. Owens JG, Kamerling SG, Stanton SR, Keowen ML, Prescott-Mathews JS. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses.. Am J Vet Res 1996 Jun;57(6):866-74.
        pubmed: 8725815
      25. de Grauw JC, Brama PA, Wiemer P, Brommer H, van de Lest CH, van Weeren PR. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.. Am J Vet Res 2006 Jul;67(7):1156-62.
        doi: 10.2460/ajvr.67.7.1156pubmed: 16817736google scholar: lookup
      26. Neumann U, Kubota H, Frei K, Ganu V, Leppert D. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.. Anal Biochem 2004 May 15;328(2):166-73.
        doi: 10.1016/j.ab.2003.12.035pubmed: 15113693google scholar: lookup
      27. Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.. J Clin Invest 1992 Dec;90(6):2268-77.
        doi: 10.1172/JCI116113pmc: PMC443378pubmed: 1281828google scholar: lookup
      28. Poole AR, Ionescu M, Swan A, Dieppe PA. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.. J Clin Invest 1994 Jul;94(1):25-33.
        doi: 10.1172/JCI117314pmc: PMC296278pubmed: 7518830google scholar: lookup
      29. Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, Fraser GL, Brooks E, Tanzer M, Rosenberg LC, Dieppe P, Robin Poole A. Evidence for altered synthesis of type II collagen in patients with osteoarthritis.. J Clin Invest 1998 Dec 15;102(12):2115-25.
        doi: 10.1172/JCI4853pmc: PMC509166pubmed: 9854047google scholar: lookup
      30. Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis.. Arthritis Rheum 2001 Jan;44(1):120-7.
        doi: 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-Xpubmed: 11212149google scholar: lookup
      31. Song Xy, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, Billinghurst RC, Poole AR, Wahl SM. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis.. J Exp Med 1999 Aug 16;190(4):535-42.
        doi: 10.1084/jem.190.4.535pmc: PMC2195606pubmed: 10449524google scholar: lookup
      32. Frisbie DD, Ray CS, Ionescu M, Poole AR, Chapman PL, McIlwraith CW. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses.. Am J Vet Res 1999 Mar;60(3):306-9.
        pubmed: 10188811
      33. Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine.. Osteoarthritis Cartilage 2002 Jan;10(1):1-4.
        doi: 10.1053/joca.2001.0488pubmed: 11795977google scholar: lookup
      34. Hawkins DL, MacKay RJ, Gum GG, Colahan PT, Meyer JC. Effects of intra-articularly administered endotoxin on clinical signs of disease and synovial fluid tumor necrosis factor, interleukin 6, and prostaglandin E2 values in horses.. Am J Vet Res 1993 Mar;54(3):379-86.
        pubmed: 8498739
      35. Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia.. Br J Pharmacol 1999 Feb;126(3):649-56.
        doi: 10.1038/sj.bjp.0702347pmc: PMC1565854pubmed: 10188975google scholar: lookup
      36. Ryu SY, Jeong KS, Yoon WK, Park SJ, Kang BN, Kim SH, Park BK, Cho SW. Somatostatin and substance P induced in vivo by lipopolysaccharide and in peritoneal macrophages stimulated with lipopolysaccharide or interferon-gamma have differential effects on murine cytokine production.. Neuroimmunomodulation 2000;8(1):25-30.
        doi: 10.1159/000026449pubmed: 10859485google scholar: lookup
      37. Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, Pillinger MH, Abramson SB. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.. J Immunol 2008 Oct 1;181(7):5082-8.
        pubmed: 18802112doi: 10.4049/jimmunol.181.7.5082google scholar: lookup
      38. Meini S, Maggi CA. Knee osteoarthritis: a role for bradykinin?. Inflamm Res 2008 Aug;57(8):351-61.
        doi: 10.1007/s00011-007-7204-1pubmed: 18787773google scholar: lookup
      39. Chu Q, Lopez M, Hayashi K, Ionescu M, Billinghurst RC, Johnson KA, Poole AR, Markel MD. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog.. Osteoarthritis Cartilage 2002 Aug;10(8):662-9.
        doi: 10.1053/joca.2002.0812pmc: PMC2048684pubmed: 12479389google scholar: lookup
      40. Lohmander LS, Ionescu M, Jugessur H, Poole AR. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.. Arthritis Rheum 1999 Mar;42(3):534-44.
        doi: 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-Jpubmed: 10088777google scholar: lookup
      41. Janusz MJ, Little CB, King LE, Hookfin EB, Brown KK, Heitmeyer SA, Caterson B, Poole AR, Taiwo YO. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.. Osteoarthritis Cartilage 2004 Sep;12(9):720-8.
        doi: 10.1016/j.joca.2004.06.004pubmed: 15325638google scholar: lookup
      42. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B, Baird AN, Hanson RR, Wright JM, Lin HC, Purohit RC. Immunohistochemical analysis of an equine model of synovitis-induced arthritis.. Am J Vet Res 1996 Jul;57(7):1080-93.
        pubmed: 8807026
      43. Hawkins DL, Cargile JL, MacKay RJ, Broome TA, Skelley LA. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin.. Am J Vet Res 1995 Oct;56(10):1292-9.
        pubmed: 8928945
      44. Petrov R, MacDonald MH, Tesch AM, Benton HP. Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism.. Osteoarthritis Cartilage 2005 Mar;13(3):250-7.
        doi: 10.1016/j.joca.2004.12.004pubmed: 15727892google scholar: lookup

      Citations

      This article has been cited 27 times.
      1. Knych HK, Weiner D, Harrison L, McKemie DS. Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis.. BMC Vet Res 2022 Dec 13;18(1):436.
        doi: 10.1186/s12917-022-03537-5pubmed: 36514067google scholar: lookup
      2. Ask K, Andersen PH, Tamminen LM, Rhodin M, Hernlund E. Performance of four equine pain scales and their association to movement asymmetry in horses with induced orthopedic pain.. Front Vet Sci 2022;9:938022.
        doi: 10.3389/fvets.2022.938022pubmed: 36032285google scholar: lookup
      3. McParland TJ, Horne CR, Robertson JB, Schnabel LV, Nelson NC. Alterations to the synovial invaginations of the navicular bone are associated with pathology of both the navicular apparatus and distal interphalangeal joint when evaluated using high field MRI.. Vet Radiol Ultrasound 2023 Jan;64(1):9-17.
        doi: 10.1111/vru.13140pubmed: 35969227google scholar: lookup
      4. Kearney CM, Khatab S, van Buul GM, Plomp SGM, Korthagen NM, Labberté MC, Goodrich LR, Kisiday JD, Van Weeren PR, van Osch GJVM, Brama PAJ. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation.. Front Vet Sci 2022;9:907616.
        doi: 10.3389/fvets.2022.907616pubmed: 35812845google scholar: lookup
      5. Aghamohammadi D, Sharifi S, Shakouri SK, Eslampour Y, Dolatkhah N. Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single-center case series.. J Med Case Rep 2022 May 8;16(1):183.
        doi: 10.1186/s13256-022-03393-9pubmed: 35526052google scholar: lookup
      6. Raeissadat SA, Rayegani SM, Jafarian N, Heidari M. Autologous conditioned serum applications in the treatment of musculoskeletal diseases: a narrative review.. Future Sci OA 2022 Feb;8(2):FSO776.
        doi: 10.2144/fsoa-2021-0088pubmed: 35070358google scholar: lookup
      7. Kamm JL, Riley CB, Parlane NA, Gee EK, McIlwraith CW. Immune response to allogeneic equine mesenchymal stromal cells.. Stem Cell Res Ther 2021 Nov 12;12(1):570.
        doi: 10.1186/s13287-021-02624-ypubmed: 34772445google scholar: lookup
      8. Cokelaere SM, Groen WMGAC, Plomp SGM, de Grauw JC, van Midwoud PM, Weinans HH, van de Lest CHA, Tryfonidou MA, van Weeren PR, Korthagen NM. Sustained Intra-Articular Release and Biocompatibility of Tacrolimus (FK506) Loaded Monospheres Composed of [PDLA-PEG(1000)]-b-[PLLA] Multi-Block Copolymers in Healthy Horse Joints.. Pharmaceutics 2021 Sep 10;13(9).
        doi: 10.3390/pharmaceutics13091438pubmed: 34575514google scholar: lookup
      9. Bittar IP, Neves CA, Araújo CT, Oliveira YVR, Silva SL, Borges NC, Franco LG. Dose-Finding in the Development of an LPS-Induced Model of Synovitis in Sheep.. Comp Med 2021 Apr 1;71(2):141-147.
        doi: 10.30802/AALAS-CM-20-000032pubmed: 33568256google scholar: lookup
      10. Zhang P, Zhu N, Du L, Zheng J, Hu S, Xu B. Treatment of simple bone cysts of the humerus by intramedullary nailing and steroid injection.. BMC Musculoskelet Disord 2020 Feb 4;21(1):70.
        doi: 10.1186/s12891-020-3054-6pubmed: 32019514google scholar: lookup
      11. Hernandez-Avalos I, Mota-Rojas D, Mora-Medina P, Martínez-Burnes J, Casas Alvarado A, Verduzco-Mendoza A, Lezama-García K, Olmos-Hernandez A. Review of different methods used for clinical recognition and assessment of pain in dogs and cats.. Int J Vet Sci Med 2019;7(1):43-54.
        doi: 10.1080/23144599.2019.1680044pubmed: 31819890google scholar: lookup
      12. Neuenschwander HM, Moreira JJ, Vendruscolo CP, Fülber J, Seidel SRT, Michelacci YM, Baccarin RYA. Hyaluronic acid has chondroprotective and joint-preserving effects on LPS-induced synovitis in horses.. J Vet Sci 2019 Nov;20(6):e67.
        doi: 10.4142/jvs.2019.20.e67pubmed: 31775194google scholar: lookup
      13. Boere J, Malda J, van de Lest CHA, van Weeren PR, Wauben MHM. Extracellular Vesicles in Joint Disease and Therapy.. Front Immunol 2018;9:2575.
        doi: 10.3389/fimmu.2018.02575pubmed: 30483255google scholar: lookup
      14. Hunt CL, Leatherwood JL, Coverdale JA, Sigler DL, Vogelsang MM, Arnold CE. Effects of repeated arthrocentesis on systemic cytokine expression and leukocyte population in young horses challenged with intra-articular lipopolysaccharide.. J Anim Sci 2019 Jan 1;97(1):184-191.
        doi: 10.1093/jas/sky423pubmed: 30423145google scholar: lookup
      15. Ma TW, Li Y, Wang GY, Li XR, Jiang RL, Song XP, Zhang ZH, Bai H, Li X, Gao L. Changes in Synovial Fluid Biomarkers after Experimental Equine Osteoarthritis.. J Vet Res 2017 Dec;61(4):503-508.
        doi: 10.1515/jvetres-2017-0056pubmed: 29978116google scholar: lookup
      16. Sladek S, Kearney C, Crean D, Brama PAJ, Tajber L, Fawcett K, Labberte MC, Leggett B, Brayden DJ. Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.. Drug Deliv Transl Res 2018 Oct;8(5):1421-1435.
        doi: 10.1007/s13346-018-0557-xpubmed: 29947020google scholar: lookup
      17. Niemelä TM, Tulamo RM, Aaltonen K, Sankari SM, Hielm-Björkman AK. Changes in biomarkers in equine synovial fluid two weeks after intra-articular hyaluronan treatment: a randomised double-blind clinical trial.. BMC Vet Res 2018 Jun 15;14(1):186.
        doi: 10.1186/s12917-018-1512-2pubmed: 29907111google scholar: lookup
      18. Vendruscolo CDP, Moreira JJ, Seidel SRT, Fülber J, Neuenschwander HM, Bonagura G, Agreste FR, Baccarin RYA. Effects of medical ozone upon healthy equine joints: Clinical and laboratorial aspects.. PLoS One 2018;13(5):e0197736.
        doi: 10.1371/journal.pone.0197736pubmed: 29813093google scholar: lookup
      19. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.. Front Vet Sci 2018;5:70.
        doi: 10.3389/fvets.2018.00070pubmed: 29713634google scholar: lookup
      20. MacNicol JL, Lindinger MI, Pearson W. A time-course evaluation of inflammatory and oxidative markers following high-intensity exercise in horses: a pilot study.. J Appl Physiol (1985) 2018 Apr 1;124(4):860-865.
        doi: 10.1152/japplphysiol.00461.2017pubmed: 29074709google scholar: lookup
      21. Swärd P, Wang Y, Hansson M, Lohmander LS, Grodzinsky AJ, Struglics A. Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity.. Arthritis Res Ther 2017 Jul 5;19(1):157.
        doi: 10.1186/s13075-017-1318-9pubmed: 28679445google scholar: lookup
      22. Bertuglia A, Pagliara E, Grego E, Ricci A, Brkljaca-Bottegaro N. Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.. BMC Vet Res 2016 Nov 8;12(1):246.
        doi: 10.1186/s12917-016-0873-7pubmed: 27821120google scholar: lookup
      23. van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA. The preventive effects of two nutraceuticals on experimentally induced acute synovitis.. Equine Vet J 2017 Jul;49(4):532-538.
        doi: 10.1111/evj.12629pubmed: 27554764google scholar: lookup
      24. Haller JM, Swearingen CA, Partridge D, McFadden M, Thirunavukkarasu K, Higgins TF. Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.. Clin Orthop Relat Res 2015 Oct;473(10):3280-8.
        doi: 10.1007/s11999-015-4441-4pubmed: 26162411google scholar: lookup
      25. Guruprasad B, Chaudhary P, Choedon T, Kumar VL. Artesunate Ameliorates Functional Limitations in Freund's Complete Adjuvant-Induced Monoarthritis in Rat by Maintaining Oxidative Homeostasis and Inhibiting COX-2 Expression.. Inflammation 2015;38(3):1028-35.
        doi: 10.1007/s10753-014-0067-zpubmed: 25425049google scholar: lookup
      26. Moreira JJ, Moraes AP, Brossi PM, Machado TS, Michelacci YM, Massoco CO, Baccarin RY. Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints.. J Vet Sci 2015;16(1):47-55.
        doi: 10.4142/jvs.2015.16.1.47pubmed: 25269714google scholar: lookup
      27. Duesterdieck-Zellmer KF, Moneta L, Ott JF, Larson MK, Gorman EM, Hunter B, Löhr CV, Payton ME, Morré JT, Maier CS. Effects of low and high dose intraarticular tiludronate on synovial fluid and clinical variables in healthy horses-a preliminary investigation.. PeerJ 2014;2:e534.
        doi: 10.7717/peerj.534pubmed: 25237596google scholar: lookup
      Subscribe to our newsletter
      Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.